Drawing for ARL BIO PHARMA

USPTO serial 87667768

ARL BIO PHARMA

Reviewed by CopyMark Law Group

Reg. 5664342Status 702Registered
Filing date
Status date
Registration date
Jan 29, 2019
Examiner
GOODWIN, KATRINA JOYE
Law office
Historical data usage

What this means

Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use. Continue use in commerce and plan for the 10-year Section 8 and 9 renewal.

Status 702: Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use.

Need help with ARL BIO PHARMA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Randall K. McCarthy

Randall K. McCarthy Hall Estill Hardwick Gable Golden & Nelson, P.C.100 N. Broadway Ave., Suite 2900Oklahoma City, OK 73102United States

Goods and services

ClassDescriptionStatusFirst use
042Laboratory research services and contract research services, namely, analytical and microbiological testing for others in the pharmaceutical industry; Laboratory analysis for others in the pharmaceutical industry in the field of pharmaceuticals; Laboratory services in the fields of pharmacology, microbiology, toxicology, and biotechnology; Laboratory analysis services for pharmaceutical manufacturers, bulk and raw material manufacturers, and compounding, hospital, and health system pharmacies industry, namely, laboratory analysis in the field of pharmaceuticals; Testing and analysis of pharmaceuticals per industry standards and for compliance with the requirements of the United States Pharmacopeia regulatory requirements; Quality control testing for others in the pharmaceutical industry; Quality management services, namely, quality evaluation and analysis, quality assurance, and quality control, in the fields of pharmacology, microbiology, toxicology, and biotechnology; Laboratory analysis services for the purpose of determining the identity, purity, potency and stability of pharmaceutical compounds; Testing of pharmaceutical raw materials to determine conformity with established regulatory standards; Development of scientific analytical and microbiological methods; Compatibility studies in the nature of testing to determine if mixing of pharmaceutical formulations affects their physical or chemical properties; Drug diversion testing in the nature of testing to confirm the identity of a pharmaceutical in a sample, to identify the presence in a sample of an unknown pharmaceutical, and to determine the concentration of a pharmaceutical in a sample; Complaint sample testing, namely, analytical and microbiological testing of a sample to determine the presence, quality and concentration of pharmaceuticals; Laboratory services, namely, chemical and biological analysis for forensic purposes; Consulting services in the fields of scientific analysis and microbiological testing; Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, pharmacogenomics, and forensic science; Laboratory research services relating to pharmaceuticalsACTIVEFeb 15, 2017

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 5, 2025NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED—
May 5, 2025C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
May 5, 2025APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Jan 16, 2025E815TEAS SECTION 8 & 15 RECEIVED—
Jan 29, 2024REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Sep 6, 2023TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Sep 6, 2023ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 6, 2023REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Sep 6, 2023CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Sep 6, 2023COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Jan 29, 2019R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Nov 13, 2018NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Nov 13, 2018PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 24, 2018NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Sep 24, 2018CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 11, 2018XAECEXAMINER'S AMENDMENT ENTERED—
Sep 11, 2018GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Sep 11, 2018GNEAEXAMINERS AMENDMENT E-MAILED—
Sep 11, 2018CNEAEXAMINERS AMENDMENT -WRITTEN—
Aug 21, 2018TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Aug 20, 2018CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 20, 2018TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 8, 2018ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 8, 2018REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Feb 21, 2018GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 21, 2018GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 21, 2018CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 13, 2018DOCKASSIGNED TO EXAMINER—
Nov 10, 2017MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED—
Nov 9, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 4, 2017NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance